By Rachel Barron
Medical device maker Boston Scientific said Thursday fourth quarter earnings fell 17 percent, as its key product, a drug-coated stent, saw a slide in sales.
Boston Scientific said fourth quarter net income was $277 million, or $0.19 per share, compared to $334 million, or $0.40 per share during the same a year ago. Net sales jumped 34 percent for the quarter to $2.07 billion, as compared to $1.54 billion for same quarter a year ago.
Investors sent Boston Scientific shares down $0.12 to $18.33.